Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults and children with FDA test-confirmed MSI-high or dMMR unresectable or metastatic solid tumors after progression on prior therapy and without satisfactory alternatives.
LAMPGEN ANALYSIS
Why it matters
The action converted the biomarker-defined, tumor-agnostic indication to traditional approval.
What research teams should watch
Verify the assay, disease setting and prior treatment, and distinguish this use from the separately labeled colorectal indication.
PRIMARY RECORDS